
Amongst other announcements at its second quarter statement, GSK’s CEO, Emma Walmsley, gave a hint towards the British-based company’s desires …

Sanofi Pasteur Korea has announced that Baptiste de Clarens will be the new General Manager of the unit, after the …

New research, led by teams from AFM-Telethon laboratory in Nantes and the University of London, have developed a gene therapy …

NICE has announced its decision to make Roche’s Gazyvaro available via the Cancer Drugs Fund (CDF) in combination with chemotherapy …

It has been announced that Celgene has agreed to settle a case after a whistle-blower launched a lawsuit against the …

Data released by NHS Digital rings a very worn bell regarding levels of staff employed and recruited the NHS, as …

Since the PD-1/PD-L1 immunotherapies have hit the market, they have revolutionised cancer care for many patients yet, with the science …

The US faces an ongoing crisis in opioid dependency, and FDA Commissioner Scott Gottlieb is prepared to employ unusual tactics …

Cardinal Health, one of the largest drug distributors in the US, is looking to sell on its network in China, …

Eli Lilly is to enter a partnership with Nektar Therapeutics to tap into the biotech’s new autoimmune disease therapy as …

Endo International has announced that it will close down its manufacturing and distribution facilities in Huntsville, Alabama, as part of …

Context Therapeutics, a biotech company that focuses on the development of treatments for Sigma1-related diseases, has announced that a new …

Homeopathy is one of the most controversial subjects within the healthcare system and NHS England has outlined its stance by …
Specialist medical education company, Wave, has boosted its editorial and programme delivery teams with two new appointments. Sadaf Kazi joins …

The British Pharmacopoeia (BP) 2018 is now published and available for purchase. An essential text for anyone working to develop …